Ameritas Investment Partners’s CVS Health CVS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$1.13M Sell
10,936
-430
-4% -$38.4K 0.03% 597
2026
Q1
$816K Buy
11,366
+1
+0% +$77 0.03% 676
2025
Q4
$902K Sell
11,365
-199
-2% -$15.7K 0.03% 651
2025
Q3
$872K Sell
11,564
-451
-4% -$30.9K 0.03% 656
2025
Q2
$829K Hold
12,015
0.03% 671
2025
Q1
$814K Sell
12,015
-249
-2% -$14.9K 0.03% 668
2024
Q4
$551K Sell
12,264
-481
-4% -$27K 0.02% 801
2024
Q3
$801K Sell
12,745
-469
-4% -$27.4K 0.03% 688
2024
Q2
$780K Sell
13,214
-401
-3% -$25.1K 0.03% 680
2024
Q1
$1.09M Sell
13,615
-661
-5% -$50.5K 0.04% 599
2023
Q4
$1.13M Sell
14,276
-547
-4% -$38.9K 0.04% 568
2023
Q3
$1.03M Sell
14,823
-383
-3% -$27.1K 0.04% 554
2023
Q2
$1.05M Sell
15,206
-429
-3% -$30.5K 0.04% 573
2023
Q1
$1.16M Sell
15,635
-401
-3% -$33.6K 0.05% 520
2022
Q4
$1.4M Sell
16,036
-281
-2% -$27.1K 0.06% 450
2022
Q3
$1.56M Sell
16,317
-92
-0.6% -$9.11K 0.07% 329
2022
Q2
$1.52M Sell
16,409
-335
-2% -$32.7K 0.07% 362
2022
Q1
$1.7M Sell
16,744
-561
-3% -$58.9K 0.06% 385
2021
Q4
$1.78M Sell
17,305
-465
-3% -$43K 0.06% 379
2021
Q3
$1.51M Sell
17,770
-378
-2% -$31.7K 0.06% 412
2021
Q2
$1.51M Hold
18,148
0.05% 426
2021
Q1
$1.36M Sell
18,148
-896
-5% -$65.3K 0.05% 461
2020
Q4
$1.3M Sell
19,044
-973
-5% -$63.3K 0.06% 428
2020
Q3
$1.17M Sell
20,017
-1,032
-5% -$64.2K 0.05% 401
2020
Q2
$1.37M Sell
21,049
-372
-2% -$23.4K 0.07% 339
2020
Q1
$1.27M Sell
21,421
-483
-2% -$32.2K 0.07% 296
2019
Q4
$1.63M Sell
21,904
-313
-1% -$22K 0.07% 313
2019
Q3
$1.4M Sell
22,217
-446
-2% -$26.4K 0.06% 363
2019
Q2
$1.24M Sell
22,663
-584
-3% -$31.4K 0.06% 417
2019
Q1
$1.25M Buy
23,247
+266
+1% +$16.4K 0.06% 415
2018
Q4
$1.51M Buy
22,981
+4,255
+23% +$318K 0.08% 288
2018
Q3
$1.47M Sell
18,726
-315
-2% -$22.5K 0.07% 357
2018
Q2
$1.23M Sell
19,041
-2,055
-10% -$135K 0.06% 438
2018
Q1
$1.31M Sell
21,096
-832
-4% -$59.7K 0.06% 415
2017
Q4
$1.59M Sell
21,928
-28,335
-56% -$2.06M 0.07% 347
2017
Q3
$3.99M Buy
50,263
+177
+0.4% +$14K 0.19% 84
2017
Q2
$4.03M Sell
50,086
-3,309
-6% -$261K 0.2% 82
2017
Q1
$4.19M Sell
53,395
-1,779
-3% -$142K 0.21% 72
2016
Q4
$4.35M Buy
55,174
+7,222
+15% +$584K 0.22% 71
2016
Q3
$4.27M Buy
47,952
+1,038
+2% +$98K 0.23% 62
2016
Q2
$4.49M Buy
46,914
+485
+1% +$48.3K 0.29% 58
2016
Q1
$4.82M Buy
46,429
+10,390
+29% +$1.01M 0.32% 54
2015
Q4
$3.52M Sell
36,039
-172
-0.5% -$16.8K 0.24% 78
2015
Q3
$3.49M Sell
36,211
-17,014
-32% -$1.79M 0.25% 72
2015
Q2
$5.58M Buy
53,225
+134
+0.3% +$13.7K 0.37% 43
2015
Q1
$5.48M Sell
53,091
-7,891
-13% -$798K 0.36% 43
2014
Q4
$5.87M Sell
60,982
-188
-0.3% -$16.6K 0.4% 42
2014
Q3
$4.87M Sell
61,170
-1,285
-2% -$101K 0.35% 48
2014
Q2
$4.71M Sell
62,455
-511
-0.8% -$38.6K 0.34% 51
2014
Q1
$4.71M Sell
62,966
-1,619
-3% -$114K 0.37% 52
2013
Q4
$4.62M Buy
64,585
+10,848
+20% +$697K 0.37% 52
2013
Q3
$3.05M Buy
53,737
+26,037
+94% +$1.55M 0.29% 63
2013
Q2
$1.58M Buy
+27,700
New +$1.6M 0.43% 97

Other funds holding CVS

Ameritas Investment Partners's CVS Position: Q2 2026 in Review

Ameritas Investment Partners reduced its CVS Health (CVS) stake by 3.8% in Q2 2026, selling an estimated $38.4K and leaving 10,936 shares worth $1.13M. The position accounts for 0.03% of the portfolio, ranked #597.

Ameritas Investment Partners first reported a position in CVS in Q2 2013 and has held it in 53 quarters since. The position peaked at $5.87M in Q4 2014. 2,061 funds tracked by Wall St. Rank hold CVS as of Q2 2026.

  • Ameritas Investment Partners held 10,936 shares of CVS Health worth $1.13M as of Q2 2026.
  • Ameritas Investment Partners sold 430 CVS Health shares in Q2 2026, an estimated $38.4K.
  • CVS Health made up 0.03% of Ameritas Investment Partners's portfolio in Q2 2026, its #597 holding.
  • Ameritas Investment Partners first reported a position in CVS Health in Q2 2013 and has held it in 53 quarters since.
  • Ameritas Investment Partners's CVS Health position peaked at $5.87M in Q4 2014.
  • 2,061 funds tracked by Wall St. Rank held CVS Health as of Q2 2026.

Based on Ameritas Investment Partners's 13F filing for Q2 2026, filed 13 Aug 2026.